StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.09−0.12 (-9.92%)

Close on Nov 16, 2026Market cap $9.82MP/E –Yield –

Lisata Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lisata Therapeutics's price to sales ratio was 109.4× on Nov 11, 2026, against 16.9× a year earlier. Over the last 5 years it ranged from 0.8× to 260.3×, with a median of 7.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026109.4×+94.2
2025Dec 31, 202515.2×+14.0
2018Feb 28, 20181.3×+0.3
2017Dec 29, 20170.9×+0.0
2016Dec 30, 20160.9×−3.1
2015Dec 31, 20154.0×−7.0
2014Apr 30, 201411.0×−41.4
2013Dec 31, 201352.3×+44.8
2012Dec 31, 20127.5×+6.3
2011Dec 30, 20111.2×–

More Lisata Therapeutics figures

See a number that looks wrong?